• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The U.S. Market for Rx to OTC Switches, 6th Edition

$3,995.00 – $7,990.00

Clear
SKU: KLI4940425 Categories: Over-the-Counter (OTC) Drugs, Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 290
  • Description
  • Table of Contents
  • Latest reports

Description

The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription.   This report represents the six time that Kalorama Information has analyzed the market for drugs with switched ingredients in detail.  The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:

  • Allergy, Cough, Cold, and Sinus Products
  • Analgesics, NSAIDs, and Pain Treatments
  • Anti-Infectives
  • Gastrointestinal Drugs
  • Hair Loss Products
  • Hormones
  • Oral Care
  • Rectal Ointments
  • Sleep-aids
  • Smoking Cessation
  • Weight Loss

In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include:

  • Blood Products
  • BPH Treatments
  • Cholesterol-reducing Drugs
  • Hormone Replacement Therapies
  • Migraine Treatments
  • Osteoporosis Treatments
  • Overactive Bladder
  • Sexual Dysfunction/ Erectile Dysfunction

The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug. Current and historical revenues for product segments include both the switched brands and OTC drugs containing switched ingredients. Forecasted data includes current products and forecasted switches which are outlined in the report.

The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers. In addition to above-mentioned information, the report includes current issues and trends affecting the industry and identifies trends that may arise in the future.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as allergy treatments, cholesterol-reducing drugs, urinary disorders treatments and hormones treatments are expected to make the most impact.

There are several companies that compete heavily in this market and use the Rx-to-OTC switch as a major part of their life-cycle management arsenal. Companies involved in the Rx-to-OTC switched market include brand, generic, and private label manufacturers. Competition will likely continue to be moderate in the OTC market, especially with the patent expiration of key products nearing. Consolidation remains a major factor in this market. Most major players have made a significant acquisition or formed a strategic alliance to increase revenues and drive growth. Product innovation, line extensions and strong promotional support are a few of the top strategies for growth in this industry.

Leading competitors offering key brand products are provided in this report. These companies include:

  • Bayer Healthcare
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Insight Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Novartis
  • Pfizer
  • Prestige Brands
  • Procter & Gamble
  • Reckitt Benckiser
  • Sanofi (Chattem)
  • TEVA

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Person-to-person, email and telephone interviews were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with approximately 50 industry officials, consultants, health providers, company representatives and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, business development managers, division managers, and product representatives.

All market data pertains to the U.S. market at the manufacturers’ level. The base year for data was 2012. Historical data are provided for 2007 through 2011, with forecast data provided for 2013 through 2017. Compound annual growth rates (CAGRs) are provided for the 2007-2012, 2012-2017 and 2007-2017 periods for each industry segment covered.”

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting the Rx-to-OTC Switches Market

Leading Competitors

CHAPTER TWO: INTRODUCTION

Overview of the Over-the-Counter Market

Development of the Rx-to-OTC Drug Market

Rx-to-OTC Industry

Economic Indicators

The FDA and Rx-to-OTC Switches

CHAPTER THREE: ALLERGY, COUGH, COLD, AND SINUS PRODUCTS

Overview

Antihistamines

Decongestants

Cough Preparations

Mast Cell Stabilizers

Ophthalmic Preparations

Description of Conditions

Allergic Rhinitis

Common Cold

Sinusitis

Hives

Ocular Allergies

Product Analysis

Switched Products

Antihistamines

Decongestants

Cough Preparations

Mast Cell Stabilizers

Ophthalmic Preparations

Prescription Products with Anticipated OTC Approvals

Xyzal

Clarinex

Astelin Nasal Spray

Atrovent Nasal Spray

Flonase

Nasacort AQ

Rhinocort

Nasonex

Beconase AQ

Market Analysis

Market Size and Forecast

Competitive Analysis

CHAPTER FOUR: ANALGESICS AND OTHER PAIN RELIEVERS

Overview

Analgesics

Nonsteroidal Anti-inflammatory Drugs

Topical Pain Relievers and Other Similar Products

Description of Conditions

Pain

Inflammation

Product Analysis

Switched Ingredients

Antipruritic

Internal analgesic/antipyretic

Oral anesthetic

Prescription Products with Anticipated OTC Approvals

Nonsteroidal anti-inflammatory drugs

Voltaren (diclofenac)

Diflunisal

Etodolac

Nabumetone

Feldene (piroxicam)

Migraine treatments

Axert

Imitrex

Maxalt

Zomig

Other Migraine Treatments

Market Analysis

Market Size and Forecast

Competitive Analysis

CHAPTER FIVE: ANTI-INFECTIVES

Overview

Antibiotics

Antifungals

Antivirals

Antiparasitics

Description of Conditions

Vaginal Infections

Athlete’s Foot

Jock Itch

Ringworm

Dandruff

Scabies and Pediculosis

Pinworm

Fungal Nail Infections

Product Analysis

Switched Ingredients

Antifungals

Anthelmintics

Antimicrobials

Pediculicides

Prescription Products with Anticipated OTC Approvals

Antivirals

Zovirax

Valtrex

Denavir

Famvir

Influenza Antivirals

Antibiotics

Antifungals

Market Analysis

Market Size and Forecast

Competitive Analysis

CHAPTER SIX: GASTROINTESTINAL DRUGS

Overview

Description of Conditions

Nausea

Diarrhea

Constipation

Heartburn

Acid reflux

Product Analysis

Switched Ingredients

Histamine H2 Inhibitors

Proton Pump Inhibitors

Antidiarrheals

Laxatives

Antiemetics

Prescription Products with Anticipated OTC Approvals

Proton Pump Inhibitors

Nexium

Protonix

Aciphex

Mucosal Protectants

Antiemetics

Market and Competitive Analysis

Market Size and Forecast

Competitive Analysis

CHAPTER SEVEN: SMOKING CESSATION PRODUCTS

Overview

Description of Conditions

Lung Cancer and Tobacco Use

Product Analysis

Switched Ingredients

Prescription Products with Anticipated OTC Approvals

Nicotrol

Chantix

Market Analysis

Market Size and Forecast

Competitive Analysis

CHAPTER EIGHT: OTHER DRUG CLASSIFICATIONS

Overview

Contraceptives

Dental Rinses and Fluorides

Hair Growth Products

Rectal Ointments

Sleep Aids

Weight Management

Description of Conditions

Pregnancy

Global Birth Rates

Abortion Rates

Contraceptive Use

Dental carries

Hereditary Hair Loss

Hemorrhoids

Sleeplessness

Obesity

Conditions with Possible Future OTC Treatments

Acne Vulgaris

Benign Prostate Hypertrophy (BPH)

Elevated Cholesterol

Erectile Dysfunction

Menopause and Hormone Replacement

Menorrhagia

Osteoporosis

Urinary Incontinence/Overactive Bladder

Product Analysis

Switched Ingredients

Contraceptives

Dental rinses and fluoride

Hair growth

Rectal ointments

Sleep aids

Weight Management

Prescription Products with Anticipated OTC Approvals

Acne Treatments

Cholesterol-reducing Drugs (antilipidemics)

Blood Products

BPH

Erectile Dysfunction

Hair Loss Treatment

Hormone-Replacement Therapies (HRT)

Osteoporosis Treatments

Overactive Bladder

Sleep Aids

Market Analysis

Current Market Segments

Short-Term New Product Segment Development; 2013-2017

Product segments with short-term potential include:

Antilipidemics

BPH Treatments

Hormone Replacement Therapy and Osteoporosis Treatments

Overactive Bladder Treatments

New Product Segments; Post 2017

Sexual Dysfunction

Competitive Analysis

CHAPTER NINE: TOTAL MARKET SUMMARY

Overview

Total market Size and Forecast

Competitive Analysis

CHAPTER TEN: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC MARKET

Introduction

Regulatory Authorities

Additional Drug Access

Using Technology or Pharmacies for Nonprescription Drug Access

Physicians and Increasing Nonprescription Drug Access

Impact on the Consumer

Online Resources for Health Information

OTC Availability

Insurance Issues and Reimbursement for OTC Drugs

Health Insurance Trends in the United States

Healthcare Flexible Spending Accounts, Health Savings Accounts and OTC Medicines

Changing the Pharmacist’s Role

Impact on the Prescription Drug Manufacturer

Strategies for Continued Product Growth

Mergers and Acquisitions

Procter & Gamble and Teva Pharmaceutical Industries

Sanofi and Chattem Consumer

Schering-Plough and Merck & Co

Wyeth and Pfizer

Reckitt Benckiser and Adams Respiratory Therapeutics

Bristol-Myers Squibb and Novartis AG

Johnson & Johnson and Pfizer

Reckitt Benckiser and Boots Healthcare

Bayer and Roche

Strategies in Switching

Dual Status Switching

Generic Competition

Direct-to-Consumer Advertising

Patent Expiration

International Trends in Rx-to-OTC Switches

Consumers around the World

Streamlined Access to OTC Drug Products in Canada

Prescription vs Over-the-Counter Industry

World Health, Demographics and Life Expectancy

Life Expectancy

Birth Rates

CHAPTER ELEVEN: COMPANY PROFILES

Introduction

Bayer Healthcare

Boehringer Ingelheim

GlaxoSmithKline

Insight Pharmaceuticals

Johnson & Johnson

Merck & Co

Novartis

Pfizer

Prestige Brands

Procter & Gamble

Reckitt Benckiser

Sanofi/Chattem

TEVA

APPENDIX: COMPANY DIRECTORY

 

    The Market for Rx-to-OTC Switches, 8th Edition
    May 5, 2022
    Global Over-the-Counter (OTC) Drug Markets
    January 23, 2018
    The US Market for Rx to OTC Switches, Forecasts to 2019, 7th Edition
    February 2, 2015
    The U.S. Market for Rx to OTC Switches, 6th Edition
    January 11, 2013

Related products

  • Placeholder image

    U.S. Market for OTC Diet Aids, The

    $3,000.00 – $6,000.00
  • Placeholder image

    Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited

    $2,995.00 – $5,990.00
  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00
  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Global Medtech Sales Exceed $500 Billion as Chronic Diseases Shape Market’s Future November 14, 2023
  • Healthcare Advances, Investments Support Laboratory Information System (LIS) Growth October 26, 2023
  • Personalized Medicine Key to IVD Procedure Volumes’ 10% Annual Growth October 19, 2023
  • RNA Sequencing: Life Sciences’ Transformative $2.6 Billion Industry October 4, 2023
  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology,...Worldwide Facial Rejuvenation Markets, 4th Edition ( Topical Rejuvenation Products,...
Scroll to top